Semaglutide (Wegovy) was approved in 2021 and tirzepatide (Zepbound) in 2023
New members starting a GLP-1 for weight loss must have a BMI of 40 or higher to qualify for coverage
Glucagon-like peptide 1 receptor agonists (GLP-1RAs) have emerged as promising therapeutic agents with potent anti-inflammatory properties and diverse clinical implications
For each treatment, mean (SEM) insulin concentrations were determined in six individual wells containing three islets per well
So I talked to my doctor about these new drugs, and she said, Lets give it a try. We did, and its been amazingly effective. After just over a year on Zepboundone of several drugs approved by the FDA for weight lossSt
With these precautions, Ozempic can be used safely, but one should always weigh the benefits against the potential risks, as we discuss next